Results 281 to 290 of about 10,598,225 (397)
Migrasomes play a crucial role in endothelial‐immune interactions in atherosclerosis. This study identifies migrasomes as amplifiers in the inflammatory cascade, driving immune‐metabolic reprogramming via “migrasome‐APP‐CD74” signaling. Blocking CD74 disrupts migrasome‐mediated signaling, attenuating atherosclerosis progression.
Kangnan Zhang+10 more
wiley +1 more source
Improved Mobility and Quality of Life Through Physical Activity Management in a Stroke Patient With Peripheral Arterial Disease: A Case Report. [PDF]
Maeno T, Matsumoto I, Harada K.
europepmc +1 more source
I-2-6 The results of extraanatomic bypass in arterial diseases
飯田 良直+3 more
openalex +2 more sources
A novel RBC indicator, ESI, is better than the traditional RBC indicators and is associated with CHF prevalence and in‐hospital death. RBC membrane lipidomics, Cer 18:0;O2/16:0, and LPE 18:0, are associated with plasma volume overload and MACE in CHF patients, but these plasma lipids could not.
Lin Zhang+12 more
wiley +1 more source
Association of dietary vitamin E intake with peripheral arterial disease: A retrospective cross-sectional study. [PDF]
Liu Q+5 more
europepmc +1 more source
Plant‐derived bioactive molecules with low solubility and permeability induce hepatocyte injury, though the mechanisms driving their hepatic effects remain poorly understood. This study identifies a novel transport pathway in which poorly soluble indirubin accumulates in the liver via macrophage‐mediated uptake in Peyer's patches, exacerbating hepatic ...
Yiqi Xu+9 more
wiley +1 more source
Schwann cells may facilitate intracranial plaque progression via neurovascular remodelingcting with vascular smooth muscle cells in atherosclerotic plaques, with the SPP1 ‐ ITGB1 signaling axis mediating this interaction as a novel mechanism. Abstract Intracranial atherosclerosis (ICAS), a common cause of ischemic stroke, remains a therapeutic ...
Zijue Wang+10 more
wiley +1 more source
Incidence and predictors of cardiovascular disease mortality and all-cause mortality in patients with type II diabetes with peripheral arterial disease. [PDF]
Rerkasem A+8 more
europepmc +1 more source